Hackensack (N.J.) University Medical Center, led by CIO and vice president Shafiq Rab, MD, is restructuring the way its clinical data is structured and shared, according to a Healthcare Informatics ...

The Fast Healthcare Interoperability Resource, or FHIR (pronounced ‘fire’), is a new term in healthcare that’s witnessing growing interest and spreading almost like fire. FHIR is the latest standard ...

Data is everything in modern healthcare. Those who know how to operate it efficiently and securely—especially when it "travels"—have the best chance for success. Introduced in 2012, Fast Health ...

For the past decade or so, HL7's Fast Healthcare Interoperability Resources standard has been enabling more widespread and intuitive data exchange across the healthcare ecosystem for a variety of ...

Health Level Seven International (HL7), a global standards development body, is diving into artificial intelligence to create frameworks and standards for safe and interoperable AI in healthcare. The ...

The health system has upgraded its clinical decision support technology to give care providers on-demand, FHIR-enabled access to important data at the point of care. Intermountain Health has launched ...

The ONC and The Sequoia Project have added new enhancements for FHIR adoption in version 2.0 of the Common Agreement, which sets thew stage for nationwide interoperability through the TEFCA framework ...

In Part 1, Dr. Don Rucker, the former National Coordinator for Health IT from 2017-2021, framed the Trusted Exchange Framework and Common Agreement's reliance on brokered protocols and page view ...

Arpan Saxena is the COO/CIO at basys.ai (based out of Harvard University), a leading healthcare AI solutions company. The healthcare industry is undergoing significant changes, with the shift toward ...

IRVING, Texas--(BUSINESS WIRE)--The Health Plan Alliance (Alliance), today announced it selected 1upHealth, a provider of a Fast Healthcare Interoperability Resources (FHIR®) native platform for ...

Informatics and Artificial Intelligence–Guided Assessment of the Regulatory and Translational Research Landscape of First-in-Class Oncology Drugs in the United States, 2018-2022 Our approach used an ...